Theraflu Relief Max Strength Powder, For Solution
NDC Package 51316-549-06
Package Information
Theraflu Relief Max Strength (acetaminophen, chlorpheniramine maleate and dextromethophan hbr) powders is ▪do not use more than directed▪take every 6 hours, while symptoms persist. This formulation utilizes a powder, for solution delivery system. Marketed by Cvs Pharmacy, this product is identified by NDC 51316-549 and is authorized under FDA application M010.
Identification & Billing
- RxCUI: 2636658 - acetaminophen 1000 MG / chlorpheniramine maleate 4 MG / dextromethorphan HBr 30 MG Powder for Oral Solution
- RxCUI: 2636658 - acetaminophen 1000 MG / chlorpheniramine maleate 4 MG / dextromethorphan hydrobromide 30 MG Powder for Oral Solution
- RxCUI: 2636658 - acetaminophen 1000 MG / chlorpheniramine maleate 4 MG / dextromethorphan hydrobromide 30 MG Granules for Oral Solution
- RxCUI: 2636658 - APAP 1000 MG / chlorpheniramine maleate 4 MG / dextromethorphan hydrobromide 30 MG Powder for Oral Solution
Clinical Specifications
- Histamine H1 Receptor Antagonists - [MoA] (Mechanism of Action)
- Histamine-1 Receptor Antagonist - [EPC] (Established Pharmacologic Class)
- Sigma-1 Agonist - [EPC] (Established Pharmacologic Class)
- Sigma-1 Receptor Agonists - [MoA] (Mechanism of Action)
- Uncompetitive N-methyl-D-aspartate Receptor Antagonist - [EPC] (Established Pharmacologic Class)
- Uncompetitive NMDA Receptor Antagonists - [MoA] (Mechanism of Action)
Regulatory & Marketing
Hierarchy Structure
- 51316 - Cvs Pharmacy
- 51316-549 - Theraflu Relief Max Strength
- 51316-549-06 - 1 POWDER, FOR SOLUTION in 1 PACKET
- 51316-549 - Theraflu Relief Max Strength
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 51316-549-06 identifies a specific commercial package of 1 powder, for solution in 1 packet of Theraflu Relief Max Strength Nighttime, a human over the counter drug labeled by Cvs Pharmacy. This powder, for solution is formulated for oral use and contains acetaminophen; chlorpheniramine maleate; dextromethorphan hydrobromide as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Cvs Pharmacy on April 17, 2023. The current certification is valid through December 31, 2026.
How is this Cvs Pharmacy product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 51316054906. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.